LuciZonger

药品简介

Originator: Hernexeos by Boehringer Ingelheim Pharmaceuticals · Manufacturer: Lucius Pharma. Indication & Dosage: LuciZonger (Zongertinib), generic Hernexeos, is a prescription medicine used to treat of adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) harboring activating mutations in the HER2 (ERBB2) tyrosine kinase domain, as identified by an FDA-approved diagnostic test, following prior systemic therapy. HERNEXEOS selectively inhibits mutant HER2 signaling, thereby suppressing tumor cell proliferation and survival. LuciZonger manufactured by Lucius Pharma Ltd. In Laos. Zongertinib has to take once daily, with or without food. Side Effects: The most common side effects of Zongertinib are: Diarrhea, Liver damage, Rash, Tiredness, Nausea, Low white blood cell levels, Low potassium levels. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。